Allara raised a $30M round, bringing total funding to $75M, with existing investors Index Ventures and GV increasing their commitments and Camino Partners.
Why it matters: Allara's $30M round and its plan to push AI from intake through treatment show how an insurance-covered virtual clinic intends to scale specialty care.
Why it matters: Scarlet's $50M round shows how AI medical device certification is becoming its own business, with named customers and a regulatory bottleneck spelled out.
Polyphron raised $20M in seed funding led by Quiet Capital, with Haystack, Gradient and Compound participating. The New York company grows donor-defined human tissue in an automated lab.
Why it matters: The interview details how Polyphron pairs lab-grown human tissue with longitudinal data to train predictive models, a concrete look at the tissue-as-verification layer for drug testing.
Why it matters: Wally's flat-fee dental membership and AI-run clinics show how subscription pricing can realign incentives in a fragmented, insurance-driven market.
Why it matters: Whoop's $575M Series G at a $10.1B valuation, nearly triple its prior mark, shows how subscription wearables are drawing sovereign funds and health institutions into consumer fitness.
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing